Cherry SE Publishes Half-Year Report 2025

Munich, 26 September 2025 – Cherry SE, a globally active manufacturer of computer input devices and digital solutions for the healthcare sector, today published its half-year report 2025 and confirmed its annual guidance of 21 July. The publication took into account the early involvement of the new CFO, Jurjen Jongma.

As already reported in advance on 18 July 2025, Cherry SE’s Group revenue in the first half of the year amounted to €46.0 million. The decline compared to the same period last year (H1 2024: €61.6 million) is primarily attributable to the targeted reduction of shipments of input devices to trading partners and the persistently subdued market demand.

The margin on adjusted Group EBITDA amounts to -4.9% (H1 2024: 4.0%), slightly above the previously reported figure of -5.0%. Costs associated with the full production relocation to China and the transformation of the Auerbach site into a development, logistics, and service center for Europe were not adjusted in the results.

In order to improve margin quality in the core business, heavily discounted sell-in measures were largely avoided, and the focus was placed on measures to optimize sell-through and sell-out rates. This was necessary to curb the gray market and to increase and stabilize market prices over the long term.

Cash and cash equivalents at the end of the half-year amounted, as previously reported, to €7.9 million (31 December 2024: €16.4 million). Through tight inventory management, stocks were further reduced to €43.1 million as of 30 June 2025 (31 December 2024: €53.7 million).

For the 2025 fiscal year, Cherry SE expects Group revenue of €100–115 million and an adjusted Group EBITDA margin between 0% and 2%.

On 11 September 2025, the Management Board of Cherry SE announced that the equity of the legal entity Cherry SE is expected to fall below half of the registered share capital. An extraordinary General Meeting will be convened promptly to inform shareholders.

About Cherry 

Cherry SE [ISIN: DE000A3CRRN9] is a global manufacturer of computer input devices such as keyboards, mice, microphones, and headsets for applications in office, gaming, and industry for hybrid work, as well as hardware and software solutions in digital healthcare. Since its founding in 1953, CHERRY has been synonymous with innovative and durable high-quality products, developed in-house, specifically to meet customer needs.

CHERRY’s operational headquarters is in Germany (Auerbach in der Oberpfalz) and it employs staff in development, services, logistics, and production sites in Germany (Auerbach), China (Zhuhai), and Austria (Vienna), as well as in multiple sales offices in Germany (Munich, Auerbach), France (Paris), Sweden (Landskrona), the USA (Kenosha), China (Shanghai) and Taiwan (Taipei).

For more information, visit:https://ir.cherry.de/en/

Contact

Cherry SE
Nicole Schillinger
Investor Relations
P: Rosental 7, c/o Mindspace, 80331 Munich
T: +49 (0) 9643 2061 848
E: ir@cherry.de